Loading...
HINT: Hierarchical interaction network for clinical-trial-outcome predictions
Fu, Tianfan Huang, Kexin Xiao, Cao Glass, Lucas M. Sun, Jimeng
Fu, Tianfan
Huang, Kexin
Xiao, Cao
Glass, Lucas M.
Sun, Jimeng
Citations
Altmetric:
Genre
Journal article
Date
2022-04-08
Advisor
Committee member
Group
Department
Statistics, Operations, and Data Science
Permanent link to this record
Collections
Research Projects
Organizational Units
Journal Issue
DOI
http://dx.doi.org/10.1016/j.patter.2022.100445
Abstract
Clinical trials are crucial for drug development but often face uncertain outcomes due to safety, efficacy, or patient-recruitment problems. We propose the Hierarchical Interaction Network (HINT) to predict clinical trial outcomes. First, HINT encodes multi-modal data (drug molecule, target disease, trial eligibility criteria) into embeddings. Then, HINT trains knowledge-embedding modules using drug pharmacokinetic and historical trial data. Finally, a hierarchical interaction graph connects all of the embeddings to capture their interactions and predict trial outcomes. HINT was trained and validated on 1,160 phase I trials, 4,449 phase II trials, and 3,436 phase III trials. It obtained 0.665, 0.620, and 0.847 F1 scores on separate test sets of 627 phase I, 1,653 phase II, and 1,140 phase III trials, respectively. HINT significantly outperforms the best baseline method on most metrics. The benchmark dataset and codes are released at https://github.com/futianfan/clinical-trial-outcome-prediction.
Description
Citation
Tianfan Fu, Kexin Huang, Cao Xiao, Lucas M. Glass, Jimeng Sun, HINT: Hierarchical interaction network for clinical-trial-outcome predictions, Patterns, Volume 3, Issue 4, 2022, 100445, ISSN 2666-3899, https://doi.org/10.1016/j.patter.2022.100445.
Citation to related work
Cell Press
Has part
Patterns, Vol. 3, Iss. 4
ADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu